Literature DB >> 25792746

Opposite cross-talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation.

Virginia Pardo1, Águeda González-Rodríguez2, Carlos Guijas3, Jesús Balsinde3, Ángela M Valverde4.   

Abstract

Chronic low grade inflammation in adipose tissue during obesity is associated with an impairment of the insulin signaling cascade. In this study, we have evaluated the impact of palmitate or oleate overload of macrophage/Kupffer cells in triggering stress-mediated signaling pathways, in lipoapoptosis, and in the cross-talk with insulin signaling in hepatocytes. RAW 264.7 macrophages or Kupffer cells were stimulated with oleate or palmitate, and levels of M1/M2 polarization markers and the lipidomic profile of eicosanoids were analyzed. Whereas proinflammatory cytokines and total eicosanoids were elevated in macrophages/Kupffer cells stimulated with palmitate, enhanced arginase 1 and lower leukotriene B4 (LTB4) levels were detected in macrophages stimulated with oleate. When hepatocytes were pretreated with conditioned medium (CM) from RAW 264.7 or Kupffer cells loaded with palmitate (CM-P), phosphorylation of stress kinases and endoplasmic reticulum stress signaling was increased, insulin signaling was impaired, and lipoapoptosis was detected. Conversely, enhanced insulin receptor-mediated signaling and reduced levels of the phosphatases protein tyrosine phosphatase 1B (PTP1B) and phosphatase and tensin homolog (PTEN) were found in hepatocytes treated with CM from macrophages stimulated with oleate (CM-O). Supplementation of CM-O with LTB4 suppressed insulin sensitization and increased PTP1B and PTEN. Furthermore, LTB4 decreased insulin receptor tyrosine phosphorylation in hepatocytes, activated the NFκB pathway, and up-regulated PTP1B and PTEN, these effects being mediated by LTB4 receptor BTL1. In conclusion, oleate and palmitate elicit an opposite cross-talk between macrophages/Kupffer cells and hepatocytes. Whereas CM-P interferes at the early steps of insulin signaling, CM-O increases insulin sensitization, possibly by reducing LTB4.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cytokine; Eicosanoid; Endoplasmic Reticulum Stress (ER Stress); Fatty Acid; Hepatocyte; Inflammation; Insulin Resistance; Macrophage; Signal Transduction; Type 2 Diabetes

Mesh:

Substances:

Year:  2015        PMID: 25792746      PMCID: PMC4416868          DOI: 10.1074/jbc.M115.649483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

Review 1.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Adipocyte metabolism and obesity.

Authors:  Alan D Attie; Philipp E Scherer
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

Review 3.  JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction.

Authors:  Giovanni Solinas; Michael Karin
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

4.  Genistein reverses free fatty acid-induced insulin resistance in HepG2 hepatocytes through targeting JNK.

Authors:  Hongwei Lei; Fu'er Lu; Hui Dong; Lijun Xu; Jianhong Wang; Yan Zhao; Zhaoyi Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

5.  Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.

Authors:  Marleen Kars; Ling Yang; Margaret F Gregor; B Selma Mohammed; Terri A Pietka; Brian N Finck; Bruce W Patterson; Jay D Horton; Bettina Mittendorfer; Gökhan S Hotamisligil; Samuel Klein
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

6.  Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling.

Authors:  Ping Song; Miao Zhang; Shuangxi Wang; Jian Xu; Hyoung Chul Choi; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

7.  Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells.

Authors:  Victor Samokhvalov; Phillip J Bilan; Jonathan D Schertzer; Costin N Antonescu; Amira Klip
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-07       Impact factor: 4.310

8.  Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome.

Authors:  Tatyana P Novgorodtseva; Yulia K Karaman; Natalia V Zhukova; Elena G Lobanova; Marina V Antonyuk; Tatyana A Kantur
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

9.  Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss.

Authors:  Margaret F Gregor; Ling Yang; Elisa Fabbrini; B Selma Mohammed; J Christopher Eagon; Gökhan S Hotamisligil; Samuel Klein
Journal:  Diabetes       Date:  2008-12-09       Impact factor: 9.461

10.  Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.

Authors:  Mirela Delibegovic; Derek Zimmer; Caitlin Kauffman; Kimberly Rak; Eun-Gyoung Hong; You-Ree Cho; Jason K Kim; Barbara B Kahn; Benjamin G Neel; Kendra K Bence
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

View more
  23 in total

1.  Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.

Authors:  Yuli Cai; Honggui Li; Mengyang Liu; Ya Pei; Juan Zheng; Jing Zhou; Xianjun Luo; Wenya Huang; Linqiang Ma; Qiuhua Yang; Shaodong Guo; Xiaoqiu Xiao; Qifu Li; Tianshu Zeng; Fanyin Meng; Heather Francis; Shannon Glaser; Lulu Chen; Yuqing Huo; Gianfranco Alpini; Chaodong Wu
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

2.  Role of LpL (Lipoprotein Lipase) in Macrophage Polarization In Vitro and In Vivo.

Authors:  Hye Rim Chang; Tatjana Josefs; Diego Scerbo; Namrata Gumaste; Yunying Hu; Lesley-Ann Huggins; Tessa J Barrett; Stephanie S Chiang; Jennifer Grossman; Svetlana Bagdasarov; Edward A Fisher; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-22       Impact factor: 8.311

Review 3.  Cell culture models of fatty acid overload: Problems and solutions.

Authors:  Nour Alsabeeh; Bruno Chausse; Pamela A Kakimoto; Alicia J Kowaltowski; Orian Shirihai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-11-15       Impact factor: 4.698

4.  Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.

Authors:  Yong Tang; Guojun Cao; Xiaobo Min; Tao Wang; Shiran Sun; Xiaolong Du; Weikang Zhang
Journal:  J Physiol Biochem       Date:  2018-07-17       Impact factor: 4.158

Review 5.  Regulation of metabolism by the innate immune system.

Authors:  Denise E Lackey; Jerrold M Olefsky
Journal:  Nat Rev Endocrinol       Date:  2015-11-10       Impact factor: 43.330

6.  SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress.

Authors:  Patricia Rada; Virginia Pardo; Maysa A Mobasher; Irma García-Martínez; Laura Ruiz; Águeda González-Rodríguez; Cristina Sanchez-Ramos; Jordi Muntané; Susana Alemany; Laura P James; Kenneth J Simpson; María Monsalve; Maria Pilar Valdecantos; Ángela M Valverde
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 7.468

7.  Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance.

Authors:  Huqun Li; Maosheng Fang; Mingzhen Xu; Shihong Li; Juan Du; Weiyong Li; Hui Chen
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

8.  5-LO inhibition ameliorates palmitic acid-induced ER stress, oxidative stress and insulin resistance via AMPK activation in murine myotubes.

Authors:  Hyun Jeong Kwak; Hye-Eun Choi; Hyae Gyeong Cheon
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

9.  Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells.

Authors:  Hao Wu; Carl Weidinger; Franziska Schmidt; Jacqueline Keye; Marie Friedrich; Cansu Yerinde; Gerald Willimsky; Zhihai Qin; Britta Siegmund; Rainer Glauben
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

Review 10.  Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders.

Authors:  Luciano Ribeiro Filgueiras; C Henrique Serezani; Sonia Jancar
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.